نتایج جستجو برای: influenza vaccines

تعداد نتایج: 116403  

BACKGROUND: Influenza outbreak has become a great lifethreateningdisease in the world. Nasal vaccines can inducesystemic IgG and mucosal IgA antibody responses, whichestablish two layers of immune defense against the infectiouspathogens like influenza. Mucosal vaccines must overcomeseveral limitations, including the mucociliary clearance andinefficient uptake of soluble antigens. Therefore, nas...

2010
David P. Fidler

One of the most controversial areas of global health diplomacy over the past five years has involved negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) (HPAI-H5N1) and pandemic 2009 influenza A (H1N1) (2009-H1N1). The limited results produced by these negotiations have stimulated calls for a new global framework to improve equitable access to in...

Journal: :PLoS ONE 2008
Xiao-Song He Tyson H. Holmes Sanae Sasaki Maria C. Jaimes George W. Kemble Cornelia L. Dekker Ann M. Arvin Harry B. Greenberg

BACKGROUND Factors affecting immune responses to influenza vaccines have not been studied systematically. We hypothesized that T-cell and antibody responses to the vaccines are functions of pre-existing host immunity against influenza antigens. METHODOLOGY/PRINCIPAL FINDINGS During the 2004 and 2005 influenza seasons, we have collected data on cellular and humoral immune reactivity to influen...

2012
Dan Zheng Yinglei Yi Ze Chen

Several global outbreaks of highly pathogenic avian influenza (HPAI) H5N1 virus have increased the urgency of developing effective and safe vaccines against H5N1. Compared with H5N1 inactivated vaccines used widely, H5N1 live-attenuated influenza vaccines (LAIVs) have advantages in vaccine efficacy, dose-saving formula, long-lasting effect, ease of administration and some cross-protective immun...

Journal: :Journal of virology 2014
Nicholas W Florek Jason T Weinfurter Sinthujan Jegaskanda Joseph N Brewoo Tim D Powell Ginger R Young Subash C Das Masato Hatta Karl W Broman Olav Hungnes Susanne G Dudman Yoshihiro Kawaoka Stephen J Kent Dan T Stinchcomb Jorge E Osorio Thomas C Friedrich

UNLABELLED Current influenza virus vaccines primarily aim to induce neutralizing antibodies (NAbs). Modified vaccinia virus Ankara (MVA) is a safe and well-characterized vector for inducing both antibody and cellular immunity. We evaluated the immunogenicity and protective efficacy of MVA encoding influenza virus hemagglutinin (HA) and/or nucleoprotein (NP) in cynomolgus macaques. Animals were ...

2013
Sarah C. Gilbert

Despite the widespread availability and use of influenza vaccines, influenza still poses a considerable threat to public health. Vaccines against seasonal influenza do not offer protection against pandemic viruses, and vaccine efficacy against seasonal viruses is reduced in seasons when the vaccine composition is not a good match for the predominant circulating viruses. Vaccine efficacy is also...

2016
Rory D. de Vries Guus F. Rimmelzwaan

Antigenic drift of seasonal influenza viruses and the occasional introduction of influenza viruses of novel subtypes into the human population complicate the timely production of effective vaccines that antigenically match the virus strains that cause epidemic or pandemic outbreaks. The development of game-changing vaccines that induce broadly protective immunity against a wide variety of influ...

2014
Anne S De Groot Lenny Moise Rui Liu Andres H Gutierrez Frances Terry Ousmane A Koita Ted M Ross William Martin

A novel avian-origin H7N9 influenza strain emerged in China in April 2013. Since its re-emergence in October-November 2013, the number of reported cases has accelerated; more than 220 laboratory-confirmed cases and 112 deaths (case fatality rate of 20-30%) have been reported. The resurgence of H7N9 has re-emphasized the importance of making faster and more effective influenza vaccines than thos...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید